Biogened Bilanço Sağlığı

Finansal Sağlık kriter kontrolleri 4/6

Biogened has a total shareholder equity of PLN39.2M and total debt of PLN21.3M, which brings its debt-to-equity ratio to 54.3%. Its total assets and total liabilities are PLN88.6M and PLN49.4M respectively. Biogened's EBIT is PLN9.0M making its interest coverage ratio 4.2. It has cash and short-term investments of PLN5.2M.

Anahtar bilgiler

54.3%

Borç/özkaynak oranı

zł21.29m

Borç

Faiz karşılama oranı4.2x
Nakitzł5.16m
Eşitlikzł39.21m
Toplam yükümlülüklerzł49.43m
Toplam varlıklarzł88.64m

Son finansal sağlık güncellemeleri

Recent updates

A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Aug 28
A Piece Of The Puzzle Missing From Biogened S.A.'s (WSE:BGD) 25% Share Price Climb

Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Aug 22
Impressive Earnings May Not Tell The Whole Story For Biogened (WSE:BGD)

Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

May 23
Investors Give Biogened S.A. (WSE:BGD) Shares A 37% Hiding

Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

May 09
Here's Why Biogened (WSE:BGD) Has A Meaningful Debt Burden

Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Feb 21
Biogened's (WSE:BGD) Promising Earnings May Rest On Soft Foundations

Is Biogened (WSE:BGD) A Risky Investment?

Feb 01
Is Biogened (WSE:BGD) A Risky Investment?

Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

Feb 01
Biogened S.A. (WSE:BGD) Looks Just Right With A 37% Price Jump

We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Jun 30
We Think Biogened (WSE:BGD) Can Stay On Top Of Its Debt

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Oct 08
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jun 29
Is Biogened (WSE:BGD) A Risky Investment?

Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

Mar 25
Does Biogened (WSE:BGD) Have A Healthy Balance Sheet?

These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Dec 09
These 4 Measures Indicate That Biogened (WSE:BGD) Is Using Debt Reasonably Well

Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Jul 29
Biogened (WSE:BGD) Has A Somewhat Strained Balance Sheet

Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Apr 30
Biogened (WSE:BGD) Seems To Use Debt Quite Sensibly

Is Biogened (WSE:BGD) A Risky Investment?

Jan 24
Is Biogened (WSE:BGD) A Risky Investment?

Finansal Durum Analizi

Kısa Vadeli Yükümlülükler: BGD's short term assets (PLN54.3M) exceed its short term liabilities (PLN32.9M).

Uzun Vadeli Yükümlülükler: BGD's short term assets (PLN54.3M) exceed its long term liabilities (PLN16.5M).


Borç-Özkaynak Tarihçesi ve Analizi

Borç Seviyesi: BGD's net debt to equity ratio (41.1%) is considered high.

Borcun Azaltılması: BGD's debt to equity ratio has increased from 42.6% to 54.3% over the past 5 years.

Borç Kapsamı: BGD's debt is well covered by operating cash flow (55.8%).

Faiz Kapsamı: BGD's interest payments on its debt are well covered by EBIT (4.2x coverage).


Bilanço


Sağlıklı şirketleri keşfedin